THE FEASIBILITY OF THE USE OF MONOCLONAL ANTIBODIES TO INTERLEUKIN 23 IN THE THERAPY OF SEVERE PSORIASIS WITH THE ELUDING EFFECT OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS ArticleЖукова О.В., Артемьева С.И., Аль-Хаватми А.А.Медицинский совет. Том 17. 2023. С. 46-52
